Danaher Co. (NYSE:DHR) Holdings Raised by Schubert & Co

Schubert & Co raised its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 1,532.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,530 shares of the conglomerate's stock after buying an additional 37,109 shares during the quarter. Danaher comprises approximately 6.1% of Schubert & Co's holdings, making the stock its 4th largest position. Schubert & Co's holdings in Danaher were worth $9,074,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Kentucky Retirement Systems Insurance Trust Fund boosted its stake in Danaher by 11.6% during the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock valued at $4,874,000 after buying an additional 2,202 shares during the last quarter. Kestra Investment Management LLC purchased a new position in shares of Danaher in the 4th quarter worth $88,000. Venturi Wealth Management LLC increased its holdings in shares of Danaher by 13.5% in the 4th quarter. Venturi Wealth Management LLC now owns 4,975 shares of the conglomerate's stock worth $1,142,000 after buying an additional 592 shares during the last quarter. D.A. Davidson & CO. raised its position in shares of Danaher by 11.6% during the 4th quarter. D.A. Davidson & CO. now owns 14,835 shares of the conglomerate's stock valued at $3,405,000 after buying an additional 1,541 shares in the last quarter. Finally, CIBC Asset Management Inc lifted its holdings in shares of Danaher by 24.4% in the 4th quarter. CIBC Asset Management Inc now owns 254,327 shares of the conglomerate's stock valued at $58,308,000 after acquiring an additional 49,964 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent research reports. Wells Fargo & Company decreased their price objective on Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research report on Thursday, January 30th. Jefferies Financial Group cut their target price on Danaher from $285.00 to $260.00 and set a "buy" rating on the stock in a research report on Wednesday, January 29th. Royal Bank of Canada restated an "outperform" rating and issued a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Citigroup cut their price objective on shares of Danaher from $285.00 to $265.00 and set a "buy" rating on the stock in a research report on Thursday, January 30th. Finally, Scotiabank initiated coverage on shares of Danaher in a report on Monday, December 23rd. They issued a "sector perform" rating and a $265.00 target price for the company. Seven analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $278.00.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company's stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 11.10% of the company's stock.

Danaher Stock Up 0.9 %

Shares of DHR traded up $1.91 during midday trading on Friday, reaching $209.86. 6,209,935 shares of the stock were exchanged, compared to its average volume of 4,574,762. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company's 50 day moving average is $226.71 and its two-hundred day moving average is $247.11. The company has a market capitalization of $151.58 billion, a P/E ratio of 39.75, a PEG ratio of 2.61 and a beta of 0.83. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the business posted $2.09 EPS. On average, sell-side analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. This is an increase from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a yield of 0.61%. Danaher's payout ratio is 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.